Empowered Funds LLC Has $8.87 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Empowered Funds LLC lifted its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 10.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,824 shares of the company's stock after purchasing an additional 2,019 shares during the period. Empowered Funds LLC's holdings in HCA Healthcare were worth $8,870,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. CreativeOne Wealth LLC acquired a new stake in HCA Healthcare during the 1st quarter valued at $231,000. Bessemer Group Inc. raised its stake in HCA Healthcare by 51.2% in the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company's stock valued at $2,543,000 after purchasing an additional 2,584 shares during the last quarter. Swedbank AB acquired a new stake in shares of HCA Healthcare during the 1st quarter worth about $95,882,000. EP Wealth Advisors LLC lifted its stake in shares of HCA Healthcare by 1.6% during the second quarter. EP Wealth Advisors LLC now owns 225,146 shares of the company's stock valued at $72,335,000 after buying an additional 3,516 shares during the period. Finally, AustralianSuper Pty Ltd grew its position in shares of HCA Healthcare by 118.5% in the third quarter. AustralianSuper Pty Ltd now owns 35,493 shares of the company's stock valued at $14,425,000 after purchasing an additional 19,247 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

Analyst Ratings Changes

A number of analysts have issued reports on HCA shares. StockNews.com lowered HCA Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Monday, November 4th. KeyCorp dropped their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating for the company in a research report on Monday, October 28th. Wells Fargo & Company boosted their price objective on shares of HCA Healthcare from $395.00 to $400.00 and gave the company an "equal weight" rating in a research note on Wednesday, November 6th. Truist Financial boosted their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a "buy" rating in a research report on Monday, August 19th. Finally, Royal Bank of Canada boosted their target price on HCA Healthcare from $378.00 to $405.00 and gave the stock an "outperform" rating in a report on Friday, August 23rd. Five research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $385.00.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the firm's stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares of the company's stock, valued at $11,438,494.76. This trade represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,155 shares of company stock worth $5,608,990. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Stock Down 0.7 %

NYSE HCA traded down $2.55 during mid-day trading on Friday, reaching $342.96. 1,863,478 shares of the company's stock traded hands, compared to its average volume of 1,186,336. The company has a market cap of $86.87 billion, a price-to-earnings ratio of 15.40, a P/E/G ratio of 1.34 and a beta of 1.68. HCA Healthcare, Inc. has a 1-year low of $238.82 and a 1-year high of $417.14. The company has a fifty day simple moving average of $385.11 and a 200-day simple moving average of $357.25. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.77%. HCA Healthcare's dividend payout ratio (DPR) is 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.